Lin stated, "we remain on track to complete the [DRAGON] study in Q4 this year." Lin shared, "the FDA recommended that we complete the 24-month study, which we are about to complete coming up in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback